|
|
|
Saturday, July 5, 2008
|
Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer
HSMN NewsFeed,
3 Jul 2008:
Regenerative Medicine, Cardiology, Personnel
[Bioheart]
|
Wyeth and Progenics Receive Approval from European Commission for RELISTOR for Opioid-Induced Constipation in Advanced Illness Patients
HSMN NewsFeed,
3 Jul 2008:
Biopharmaceuticals, Regulatory
[Progenics Pharmaceuticals, Wyeth Pharmaceuticals, RELISTOR]
|
Seven Major U.S. Cancer Institutions Order Hyperthermia Systems from BSD Medical
HSMN NewsFeed,
3 Jul 2008:
Devices, Oncology
[BSD Medical, BSD-500, hyperthermia therapy]
|
Mylan Announces Tentative FDA Approval for Generic Version of Antibiotic Zyvox(R) Tablets
HSMN NewsFeed,
3 Jul 2008:
Biopharmaceuticals, Generics, FDA
[Mylan, Linezolid, Zyvox, Pfizer]
|
APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, USP
HSMN NewsFeed,
3 Jul 2008:
Biopharmaceuticals, Generics, FDA
[APP Pharmaceuticals, Granisetron, Kytril, Roche Group]
|
Adolor Provides Update on Entereg(R) (alvimopan) OBD Program
HSMN NewsFeed,
3 Jul 2008:
Biopharmaceuticals, FDA
[Adolor, Entereg, alvimopan, opioid bowel dysfunction]
|
Transition Therapeutics Announces Executive Management Appointments
HSMN NewsFeed,
3 Jul 2008:
Biopharmaceuticals, Personnel
[Transition Therapeutics]
|
Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
HSMN NewsFeed,
3 Jul 2008:
Biopharmaceuticals, Mergers & Acquisitions
[Shire plc, Jerini AG, FIRAZYR, Icatibant, hereditary angioedema]
|
Nabriva Therapeutics Announces Appointment of New CEO
HSMN NewsFeed,
3 Jul 2008:
Biopharmaceuticals, Personnel
[Nabriva Therapeutics]
|
Natus Medical Acquires Schwarzer GmbH Neurology Division
HSMN NewsFeed,
2 Jul 2008:
Devices, Neurology, Acquisitions
[Natus Medical, Schwarzer GmbH]
|
Hospitals, Healthcare Providers to Realize Value with Premier Third Party Scope Repair Agreements
HSMN NewsFeed,
2 Jul 2008:
Devices, Group Purchasing
[Premier Purchasing, Cardinal Health, FrontLine Medical]
|
Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing
HSMN NewsFeed,
2 Jul 2008:
Devices, Acquisitions
[Neovasc Inc, Medical Ventures Corp, B-Balloon]
|
Pearl Therapeutics Closes $18 Million Financing Round Led By Committed Investors
HSMN NewsFeed,
2 Jul 2008:
Biopharmaceuticals, Venture Capital
[Pearl Therapeutics]
|
CryoCath Appoints Vice President, Europe
HSMN NewsFeed,
2 Jul 2008:
Devices, Cardiology, Personnel
[CryoCath Technologies]
|
Visionsense Announces Food and Drug Administration (FDA) 510(k) Clearance for Neurosurgery
HSMN NewsFeed,
2 Jul 2008:
Devices, Neurosurgery
[Visionsense, VSII, Stereoscopic Vision System]
|
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V.
HSMN NewsFeed,
2 Jul 2008:
Biopharmaceuticals
[Cubist Pharmaceuticals, AstraZeneca, MERREM, meropenem, antibiotic]
|
Bayer HealthCare and Maxygen Announce Hematology Agreement
HSMN NewsFeed,
2 Jul 2008:
Biopharmaceuticals, Licensing, Acquisitions
[Maxygen, Bayer HealthCare, Factor VIIa, MAXY-VII, hemophilia]
|
Montecito Medical Ventures Announces Alliance With Accuray, a Leading Developer of Cancer Treatment Technology
HSMN NewsFeed,
1 Jul 2008:
Devices, Oncology
[Montecito Medical Ventures, Accuray, CyberKnife, radiosurgery]
|
TomoTherapy Concludes Treatment Quality Challenge
HSMN NewsFeed,
1 Jul 2008:
Devices, Oncology
[TomoTherapy, Hi·Art, RapidArc, Varian Medical Systems, IMRT, radiotherapy]
|
ONI BioPharma Appoints New Chief Operational Officer
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals, Personnel
[ONI BioPharma]
|
Teva Provides Update on Generic Seroquel(R) Litigation
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals, Generics, Litigation
[Teva Pharmaceutical, Quetiapine, AstraZeneca, Seroquel]
|
Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals, Oncology
[Eisai, Dacogen, decitabine, myelodysplastic syndromes]
|
nSpire Health Awarded Three-Year Agreement with Premier Group Purchasing Organization
HSMN NewsFeed,
1 Jul 2008:
Devices, Group Purchasing
[ nSpire Health, Premier Purchasing, HDpft]
|
IBT Laboratories Names Maureen Loftus President and Chief Operating Officer
HSMN NewsFeed,
1 Jul 2008:
Diagnostics, Personnel
[IBT Laboratories]
|
Repligen Elects Alfred L. Goldberg, Ph.D. to the Board of Directors
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals, Personnel
[Repligen]
|
Bausch & Lomb Names Dr. John W. Sheets, Jr., as Corporate Vice President and Chief Technology Officer
HSMN NewsFeed,
1 Jul 2008:
Devices, Ophthalmology, Personnel
[Bausch & Lomb]
|
SenoRx Receives Additional 510(k) Clearance for Its Contura MLB
HSMN NewsFeed,
1 Jul 2008:
Devices, Oncology, FDA
[SenoRx, Radiation Balloon, lumpectomy, breast cancer]
|
Ikaria(R) Strengthens Research & Development Team
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals, Personnel
[Ikaria Holdings]
|
Synthetic Blood International Changes Name to Oxygen Biotherapeutics, Inc.
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals
[Oxygen Biotherapeutics, Synthetic Blood International, Oxycyte]
|
Medical Tactile, Inc. Announces Appointment of Denis A. O'Connor as CEO & Member of Board of Directors
HSMN NewsFeed,
1 Jul 2008:
Devices, Personnel
[Medical Tactile]
|
Bentley Pharmaceuticals Completes Spin-off of Drug Delivery Business
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals, Drug Delivery, Mergers & Acquisitions
[Bentley Pharmaceuticals, CPEX Pharmaceuticals, Teva Pharmaceutical]
|
Sciele Pharma Signs Agreement with Addrenex Pharmaceuticals To Develop and Market ADX415 for the Treatment of Hypertension
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals
[Sciele Pharma, Addrenex Pharmaceuticals, ADX415, hypertension]
|
Avid Appoints Richard A. Baron as Chief Financial Officer
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals, Personnel
[Avid Radiopharmaceuticals]
|
Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
HSMN NewsFeed,
1 Jul 2008:
Devices, Monitoring, Endocrinology
[Echo Therapeutics, Glucose Monitor]
|
Welch Allyn Lighting Products Hires International Sales Manager, Service Manager
HSMN NewsFeed,
1 Jul 2008:
Devices, Personnel
[Welch Allyn]
|
SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals, Oncology
[SuperGen, Dacogen, decitabine, myelodysplastic syndromes]
|
IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following June Meeting of European Committee for Medicinal Products for Human Use (CHMP)
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals, Regulatory
[IDM Pharma, INT-0133, L-MTP-PE]
|
CoLucid Pharmaceuticals Announces $25 Million Series B Financing for Advancement of First-in-Class Migraine Compound
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals, Venture Capital
[CoLucid Pharmaceuticals]
|
Abbott Invests Additional $20M in Isis' Subsidiary Ibis Biosciences
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals
[Isis Pharmaceuticals, Ibis Biosciences, Abbott, Ibis T5000]
|
EPIX Pharmaceuticals Announces Resubmission of New Drug Application for Vasovist(R)
HSMN NewsFeed,
1 Jul 2008:
Biopharmaceuticals
[EPIX Pharmaceuticals, Vasovist, gadofosveset, magnetic resonance angiography]
|
Clarient Launches New Colorectal Cancer Test
HSMN NewsFeed,
1 Jul 2008:
Diagnostics, Oncology
[Clarient, KRAS , colorectal cancer]
|
FDA Grants Conditional Approval to Interventional Spine's PercuDyn(TM) System IDE Application
HSMN NewsFeed,
1 Jul 2008:
Devices, Neurosurgery, Orthopaedic, FDA
[Interventional Spine, PercuDyn, degenerative disc disease, spine surgery]
|
Orthofix International Promotes Brad Mason to Group President, North America
HSMN NewsFeed,
30 Jun 2008:
Devices, Orthopaedic, Personnel
[Orthofix International]
|
Acusphere Announces FDA Acceptance of Imagify(TM) NDA for Detection of Coronary Artery Disease
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Cardiology, FDA
[Acusphere, Imagify, Perflubutane Polymer Microspheres]
|
Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial
HSMN NewsFeed,
30 Jun 2008:
Devices, Cardiology
[Prescient Medical, vProtect, Luminal Shield, SECRITT I, vulnerable plaque]
|
FDA Approves EVOLENCE(R), a New Generation Collagen-Based Facial Filler
HSMN NewsFeed,
30 Jun 2008:
Devices, Dermatology, FDA
[OrthoNeutrogena, Johnson & Johnson, EVOLENCE, dermal filler]
|
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Elavil(R)
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Generics, FDA
[Caraco Pharmaceutical, Amitriptyline, Elavil, AstraZeneca]
|
Genaera Corporation Elects Paul K. Wotton to Board of Directors
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Personnel
[Genaera Corp]
|
FDA Clears First Automated Whole Blood Processing System in U.S.
HSMN NewsFeed,
30 Jun 2008:
Devices, FDA
[Gambro, CaridianBCT, Atreus , Whole Blood Processing]
|
Indevus Receives Approvable Letter from FDA for NEBIDO(R)
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, FDA
[Indevus Pharmaceuticals, NEBIDO, testosterone]
|
Anika Therapeutics Announces Commercial Availability of MONOVISC(TM) in Europe
HSMN NewsFeed,
30 Jun 2008:
Devices, Orthopaedic
[Anika Therapeutics, MONOVISC, hyaluronic acid, viscosupplement, osteoarthritis]
|
GlaxoSmithKline Responds to FDA on CERVARIX(R) and Plans to Submit Final Study Data for Approval
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Oncology, FDA
[GlaxoSmithKline, CERVARIX, cervical cancer, cancer vaccine]
|
Crystalens HD(TM) Receives FDA Approval
HSMN NewsFeed,
30 Jun 2008:
Devices, Ophthalmology, FDA
[Bausch & Lomb, Crystalens HD, intraocular lens]
|
V.A.C.(R) Therapy Clinical Study in Japan Shows Significant Efficacy in the Treatment of Acute Wounds
HSMN NewsFeed,
30 Jun 2008:
Devices, Wound Care
[Kinetic Concepts, V.A.C. Therapy]
|
SPO Medical Launching Enhanced PulseOx 7500(TM) Oximetry System
HSMN NewsFeed,
30 Jun 2008:
Devices, Monitoring
[SPO Medical, PulseOx 7500, Sleep Apnea]
|
Cohera Medical Names Richard L. Wonsettler as Company's First CFO
HSMN NewsFeed,
30 Jun 2008:
Devices, Surgery, Personnel
[Cohera Medical]
|
Cadient Group President and CEO, Stephen Wray, Named 2008 Ernst & Young Entrepreneur Of The Year(R) in Greater Philadelphia Region
HSMN NewsFeed,
30 Jun 2008:
Personnel
[Cadient Group]
|
Noven Names Anthony Venditti Vice President - Marketing & Sales
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Personnel
[Noven Pharmaceuticals]
|
BSD Medical Reports Status on Submissions to FDA
HSMN NewsFeed,
30 Jun 2008:
Devices, Oncology, FDA
[BSD Medical, BSD-2000, Hyperthermia, MicroThermX]
|
The Center for Radiation Therapy of Beverly Hills is First in California to Treat Cancer Patients with RapidArc(TM) Radiotherapy Technology
HSMN NewsFeed,
30 Jun 2008:
Devices, Oncology
[Varian Medical Systems, RapidArc, radiotherapy, IMRT]
|
Introgen Submits ADVEXIN(R) Regulatory Applications in the U.S. and Europe
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Oncology, FDA, Regulatory
[Introgen Therapeutics, ADVEXIN, p53, head and neck cancer]
|
Luminetx(R) Signs Deal with Novation
HSMN NewsFeed,
30 Jun 2008:
Devices, Group Purchasing
[Luminetx, Novation, VeinViewer]
|
William D. Schwieterman, M.D. Joins Chelsea Therapeutics' Board of Directors
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Personnel
[Chelsea Therapeutics]
|
Hana Biosciences Receives U.S. Orphan Drug Designation for Marqibo for the Treatment of Metastatic Uveal Melanoma
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Oncology, FDA
[Hana Biosciences, Marqibo, vincristine, OPTISOME, metastatic uveal melanoma]
|
Tobira Therapeutics Inc. Announces Senior Management Team
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Personnel
[Tobira Therapeutics]
|
New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Drug Delivery, FDA
[United Therapeutics, Lung Rx, treprostinil, pulmonary arterial hypertension]
|
Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Devices, Drug Delivery
[Anesiva, Zingo, lidocaine]
|
Akesis Pharmaceuticals Names Carl LeBel as President and Chief Operating Officer
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Personnel
[Akesis Pharmaceuticals]
|
Thermage, Inc. Appoints New Vice President of Research & Development
HSMN NewsFeed,
30 Jun 2008:
Devices, Dermatology, Personnel
[Thermage]
|
ADVENTRX Settles Dispute With Former Licensee
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Licensing, Litigation
[ADVENTRX Pharmaceuticals, Theragenex, TRx Pharma]
|
Nucletron Appoints New Chief Executive Officer
HSMN NewsFeed,
30 Jun 2008:
Devices, Oncology, Personnel
[Nucletron, radiation therapy]
|
Odanacatib, an Investigational Cathepsin K Inhibitor, Reduced Markers of Bone Turnover in Women with Breast Cancer and Bone Metastases
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Oncology
[Merck, odanacatib, cathepsin K, breast cancer, bone metastases]
|
Ceftobiprole, a new anti-MRSA broad-spectrum antibiotic, receives its first marketing authorization by Health Canada
HSMN NewsFeed,
30 Jun 2008:
Biopharmaceuticals, Regulatory
[Basilea Pharmaceutica, ceftobiprole, ZEFTERA, MRSA]
|
|
|
|
|
Public
Feeds 
Full text >>